Status: Recruiting
Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
This is a prospective, Phase 3, randomized, double-blind, placebo-controlled efficacy study to evaluate celiprolol in patients genetically confirmed as COL3A1-positive vEDS using a decentralized clinical trial design.
Participants needed: 150
Trial details
Phase: Phase 3Age: 15-64Biological sex: AllType: InterventionalSponsor: Acer Therapeutics Inc.Updated: Aug 24, 2025Locations: 1
Eligibility criteria
Willingness to obtain magnetic resonance angiogram (MRA) image at local imaging... [+3]
Lack of a COL3A1-positive test at screening (e.g., COL3A1 benign, likely benign,... [+6]